ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined by the lack of immunohistochemical expression of the estrogen receptor (ER) and progesterone receptor (PR) and the absence of human epidermal growth factor receptor 2 (HER-2) overexpression.